These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 28566275)

  • 1. Fibroblast-adapted human CMV vaccines elicit predominantly conventional CD8 T cell responses in humans.
    Murray SE; Nesterenko PA; Vanarsdall AL; Munks MW; Smart SM; Veziroglu EM; Sagario LC; Lee R; Claas FHJ; Doxiadis IIN; McVoy MA; Adler SP; Hill AB
    J Exp Med; 2017 Jul; 214(7):1889-1899. PubMed ID: 28566275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Vaccination of Hematopoietic Cell Transplantation Recipients Improves Protective CD8 T-Cell Immunotherapy of Cytomegalovirus Infection.
    Gergely KM; Podlech J; Becker S; Freitag K; Krauter S; Büscher N; Holtappels R; Plachter B; Reddehase MJ; Lemmermann NAW
    Front Immunol; 2021; 12():694588. PubMed ID: 34489940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dominant Antiviral CD8
    Pardieck IN; van Duikeren S; Veerkamp DMB; Brasem DJ; Redeker A; van Bergen J; Han W; Ossendorp F; Zondag G; Arens R
    Front Immunol; 2022; 13():680559. PubMed ID: 35154089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid cell tropism enables MHC-E-restricted CD8
    Hansen SG; Hancock MH; Malouli D; Marshall EE; Hughes CM; Randall KT; Morrow D; Ford JC; Gilbride RM; Selseth AN; Trethewy RE; Bishop LM; Oswald K; Shoemaker R; Berkemeier B; Bosche WJ; Hull M; Silipino L; Nekorchuk M; Busman-Sahay K; Estes JD; Axthelm MK; Smedley J; Shao D; Edlefsen PT; Lifson JD; Früh K; Nelson JA; Picker LJ
    Sci Immunol; 2022 Jun; 7(72):eabn9301. PubMed ID: 35714200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus.
    Hansen SG; Powers CJ; Richards R; Ventura AB; Ford JC; Siess D; Axthelm MK; Nelson JA; Jarvis MA; Picker LJ; Früh K
    Science; 2010 Apr; 328(5974):102-6. PubMed ID: 20360110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-specific T cell responses induced by Towne cytomegalovirus (CMV) vaccine in CMV-seronegative vaccine recipients.
    Jacobson MA; Sinclair E; Bredt B; Agrillo L; Black D; Epling CL; Carvidi A; Ho T; Bains R; Adler SP
    J Clin Virol; 2006 Mar; 35(3):332-7. PubMed ID: 16387547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ad-gBCMVpoly: A novel chimeric vaccine strategy for human cytomegalovirus-associated diseases.
    Zhong J; Khanna R
    J Clin Virol; 2009 Dec; 46 Suppl 4():S68-72. PubMed ID: 19646921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of Adaptive NK Cells and CD8 T Cells by HLA-C Correlates with Allogeneic Hematopoietic Cell Transplantation and with Cytomegalovirus Reactivation.
    Horowitz A; Guethlein LA; Nemat-Gorgani N; Norman PJ; Cooley S; Miller JS; Parham P
    J Immunol; 2015 Nov; 195(9):4524-36. PubMed ID: 26416275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virology. A vaccine monkey wrench?
    Hengel H; Koszinowski UH
    Science; 2010 Apr; 328(5974):51-2. PubMed ID: 20360096
    [No Abstract]   [Full Text] [Related]  

  • 10. Broadly targeted CD8⁺ T cell responses restricted by major histocompatibility complex E.
    Hansen SG; Wu HL; Burwitz BJ; Hughes CM; Hammond KB; Ventura AB; Reed JS; Gilbride RM; Ainslie E; Morrow DW; Ford JC; Selseth AN; Pathak R; Malouli D; Legasse AW; Axthelm MK; Nelson JA; Gillespie GM; Walters LC; Brackenridge S; Sharpe HR; López CA; Früh K; Korber BT; McMichael AJ; Gnanakaran S; Sacha JB; Picker LJ
    Science; 2016 Feb; 351(6274):714-20. PubMed ID: 26797147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of human pancreatic β cells for cytomegalovirus infection and the effects on cellular immunogenicity.
    Smelt MJ; Faas MM; de Haan BJ; Draijer C; Hugenholtz GC; de Haan A; Engelse MA; de Koning EJ; de Vos P
    Pancreas; 2012 Jan; 41(1):39-49. PubMed ID: 22158077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8 T cell-evasive functions of human cytomegalovirus display pervasive MHC allele specificity, complementarity, and cooperativity.
    Ameres S; Besold K; Plachter B; Moosmann A
    J Immunol; 2014 Jun; 192(12):5894-905. PubMed ID: 24808364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping and Characterization of HCMV-Specific Unconventional HLA-E-Restricted CD8 T Cell Populations and Associated NK and T Cell Responses Using HLA/Peptide Tetramers and Spectral Flow Cytometry.
    Rousselière A; Delbos L; Bressollette C; Berthaume M; Charreau B
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific recognition of the viral protein UL18 by CD85j/LIR-1/ILT2 on CD8+ T cells mediates the non-MHC-restricted lysis of human cytomegalovirus-infected cells.
    Saverino D; Ghiotto F; Merlo A; Bruno S; Battini L; Occhino M; Maffei M; Tenca C; Pileri S; Baldi L; Fabbi M; Bachi A; De Santanna A; Grossi CE; Ciccone E
    J Immunol; 2004 May; 172(9):5629-37. PubMed ID: 15100307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-E: exploiting pathogen-host interactions for vaccine development.
    Sharpe HR; Bowyer G; Brackenridge S; Lambe T
    Clin Exp Immunol; 2019 May; 196(2):167-177. PubMed ID: 30968409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of vaccination with rhesus CMV (RhCMV) soluble gB with a RhCMV replication-defective virus deleted for MHC class I immune evasion genes in a RhCMV challenge model.
    Valencia S; Gill RB; Dowdell KC; Wang Y; Hornung R; Bowman JJ; Lacayo JC; Cohen JI
    Vaccine; 2019 Jan; 37(2):333-342. PubMed ID: 30522906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine CMV Expressing the High Affinity NKG2D Ligand MULT-1: A Model for the Development of Cytomegalovirus-Based Vaccines.
    Hiršl L; Brizić I; Jenuš T; Juranić Lisnić V; Reichel JJ; Jurković S; Krmpotić A; Jonjić S
    Front Immunol; 2018; 9():991. PubMed ID: 29867968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection.
    Wang Z; La Rosa C; Lacey SF; Maas R; Mekhoubad S; Britt WJ; Diamond DJ
    J Clin Virol; 2006 Mar; 35(3):324-31. PubMed ID: 16388983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor predictive value of cytomegalovirus (CMV)-specific T cell assays for the development of CMV retinitis in patients with AIDS.
    Jacobson MA; Tan QX; Girling V; Poon C; Van Natta M; Jabs DA; Inokuma M; Maecker HT; Bredt B; Sinclair E;
    Clin Infect Dis; 2008 Feb; 46(3):458-66. PubMed ID: 18173357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection.
    Cui X; Meza BP; Adler SP; McVoy MA
    Vaccine; 2008 Oct; 26(45):5760-6. PubMed ID: 18718497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.